GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PYC Therapeutics Ltd (GREY:PLOGF) » Definitions » Deferred Policy Acquisition Costs

PYC Therapeutics (PYC Therapeutics) Deferred Policy Acquisition Costs


View and export this data going back to 2019. Start your Free Trial

What is PYC Therapeutics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


PYC Therapeutics (PYC Therapeutics) Business Description

Industry
Traded in Other Exchanges
Address
6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.